FDA Inspection
Sofie Co.Sofie Co. – FDA Inspection, Apr 12, 2019
Record Details
This FDA Inspection record concerns Sofie Co., with an inspection on April 12, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · e7660e90-e40a-49e5-ba38-7dc5305767d8
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1086058
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
3- 21 CFR 212.100(a)Written complaint procedures
- 21 CFR 212.30(a)Orderly handling, prevention of mix-ups, prevention of contamination
- 21 CFR 212.60(c)Analytical methods
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Sofie Co.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| January 22, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 22, 2021 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 5, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Sofie Co.
- FDA Inspection 1227438 - 2024-01-22
- FDA Inspection 1153202 - 2021-09-22
- FDA Inspection 890361 - 2014-08-05
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.